Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma

被引:24
|
作者
Tarasova, V. D. [1 ]
Tuttle, R. M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词
Low risk thyroid cancer; papillary microcarcinoma; staging; BRAF V600E MUTATION; ACTIVE SURVEILLANCE; RADIOACTIVE IODINE; CARCINOMA; ASSOCIATION; RECURRENCE; STRATIFICATION; SURGERY; PROGNOSIS; IMPACT;
D O I
10.1016/j.clon.2016.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 50 条
  • [1] Insights into the Management of Papillary Microcarcinoma of the Thyroid
    Miyauchi, Akira
    Ito, Yasuhiro
    Oda, Hitomi
    THYROID, 2018, 28 (01) : 23 - 31
  • [2] Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma
    Miyauchi, Akira
    Ito, Yasuhiro
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 215 - +
  • [3] Management of Papillary Thyroid Microcarcinoma
    Brito, Juan P.
    Hay, Ian D.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 199 - +
  • [4] Current management of papillary thyroid microcarcinoma in Canada
    Merdad, Mazin
    Eskander, Antoine
    De Almeida, John
    Freeman, Jeremy
    Rotstein, Lorne
    Ezzat, Shereen
    Sawka, Anna M.
    Goldstein, David P.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 43 : 32
  • [5] Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach
    Ramundo, Valeria
    Sponziello, Marialuisa
    Falcone, Rosa
    Verrienti, Antonella
    Filetti, Sebastiano
    Durante, Cosimo
    Grani, Giorgio
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (06) : 958 - 963
  • [6] Extent of Surgery for Low-Risk Differentiated Thyroid Cancer
    McDow, Alexandria D.
    Pitt, Susan C.
    SURGICAL CLINICS OF NORTH AMERICA, 2019, 99 (04) : 599 - +
  • [7] Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
    Ito, Y.
    Miyauchi, A.
    Oda, H.
    EJSO, 2018, 44 (03): : 307 - 315
  • [8] Active surveillance of low-risk papillary thyroid microcarcinoma
    Sugitani, Iwao
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (01)
  • [9] Papillary microcarcinoma of the thyroid gland: current controversies and management
    Rovira, Aleix
    Nixon, Iain J.
    Simo, Ricard
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2019, 27 (02) : 110 - 116
  • [10] Clinical management of low-risk papillary thyroid microcarcinoma
    Masaki, Chie
    Sugino, Kiminori
    Ito, Koichi
    MINERVA ENDOCRINOLOGY, 2021, 46 (04): : 413 - 427